Affordable Access

Access to the full text

Earlier the better: convalescent plasma

Authors
  • Tobian, Aaron A. R.1
  • Shaz, Beth H.2
  • 1 The Johns Hopkins University School of Medicine;
  • 2 New York Blood Center Enterprises
Type
Published Article
Journal
Blood
Publisher
American Society of Hematology
Publication Date
Aug 06, 2020
Volume
136
Issue
6
Pages
652–654
Identifiers
DOI: 10.1182/blood.2020007638
PMID: 32761223
PMCID: PMC7414595
Source
PubMed Central
License
Green

Abstract

In the current issue of Blood , Xia et al evaluate the use of convalescent plasma for the treatment of patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19). 1 , 2 SARS-CoV-2 has spurred a global crisis. To date, there are limited treatment options for COVID-19 and no proven prophylactic therapies for those who have been exposed to SARS-CoV-2.

Report this publication

Statistics

Seen <100 times